The company is constructing the first-ever cannabis mall, offering products manufactured in-house and serving outside vendors GCGX is reaching into the Lake Tahoe, California-area to provide products to more than 30 million who have limited or no access to recreational dispensaries The company is adding a medical grade nutraceutical division GCGX aims to commence the … Continue reading “Global Consortium Inc. (GCGX) Expands Reach, Building First-Ever Cannabis Mall”
The company’s annual license for manufacturing recreational and medicinal cannabis products was recently renewed by the State of California GCGX’s cannabis mall is under construction in Sacramento, with a goal of beginning production of Infused Edibles products there by the end of the second quarter The company’s ultimate goal is to be listed and traded … Continue reading “Global Consortium Inc. (GCGX) Finalizing Financial Reports, Anticipates Registration Process for Nasdaq Listing”
During an investor conference call, GCGX’s CEO noted that the company’s ultimate goal is to be listed and traded on the Nasdaq California has issued an annual license for adult and medicinal cannabis manufacturing to Global Consortium Group LLC CEO Dwyer added that GCGX subsidiary Infused Edibles is expected to see its production operations relocated … Continue reading “Global Consortium Inc. (GCGX) Says Uplisting Process is Underway, Receives Annual Cannabis Manufacturing License”
Nutraceuticals market growth is anticipated to create new opportunities for companies that are already well-established in the industry Recently, Global Consortium announced the addition of a medical-grade nutraceutical division to its subsidiary, Infused Edibles The new nutraceutical formulas will be developed and tested at a California facility prior to hitting the market, with the first … Continue reading “Worldwide Nutraceuticals Market Continues Rapid Growth, Global Consortium Inc. (GCGX) Positioned to Benefit from Positive Dynamics”
GCGX is a diversified cannabis holding company with $100 million in projected revenue for 2019 The company’s nutraceuticals division is to be overseen by medical physicians and veterinarians focused on diverse specialties GCGX’s product line is developed with proprietary infused formulas to include lotions, balms, ointments, liquids, pills and powders Discussions are underway to take … Continue reading “Global Consortium Inc. (GCGX) Establishes New Nutraceuticals Line, Explores Taking One Division Public in Canada”
Global Consortium (OTC: GCGX) this morning announced that it is participating in ongoing discussions to take one of its divisions public in Canada, where it can receive a higher multiple and gain easier access to capital for expansion. Cannabis companies have thrived after going public on the CSE and dual listing in the United States, … Continue reading “NetworkNewsBreaks – Global Consortium, Inc (GCGX) Exploring Opportunity to Take One of its Divisions Public in Canada”
